John G. Aunins, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 1,738 shares at $11.02 ($19K) on 2018-01-26, disclosed to the SEC on 2018-01-30.
Open-market sale of $19k MCRB by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2018-10-16 | $170K | — | Filing → |
| MCRB | SELL | 2018-09-19 | $655K | — | Filing → |
| MCRB | SELL | 2018-07-18 | $231K | — | Filing → |